[Neuromuscular monitoring: methods and machines].
Muscle relaxing agents are clinically in use for general anaesthesia to optimize the conditions to the endotracheal intubation as well as the surgical conditions. Therefore different musclerelaxants with specific pharmacological characteristics are available. Many factors that depend on the condition of the patient and the used musclerelaxant agent influence the duration of the neuromuscular blockade. Rapid reversal of their effects, particularly in cases of profound blockades, proved to be difficult. In cases of postoperative residual paralysis hypoxic complications because of failure of the ventilation increase the morbidity and mortality of the perioperative period. To avoid these complications in cause of postoperative residual neuromuscular blockade it seems to be necessary to evaluate the status of the muscle function. For the tactile or visual assessment or the objective measurement of stimulation the train-of-four (TOF), double-burst (DBS) or tetanus-stimulation of peripheral nerves like the ulnar nerve may be used. Established methods for the objective monitoring of neuromuscular function is the mechanomyography (MMG), the acceleromyography (AMG), the electromyography (EMG), the kinemyography (KMG) and the phonomyography (PMG). A sufficient recovery of the neuromuscular transmission is reached to a TOF-ratio of 0,9 and should be aimed before the extubation at the end of surgery. No subjective evaluation of the neuromuscular recovery is able to identify residual paralysis above a TOF-ratio of 0,5. Recent studies suggest that objective methods should be used to monitor neuromuscular function to avoid postoperative residual blockades.
Nauheimer
Dirk
D
Zentrum für Anästhesiologie, Intensiv-, Notfallmedizin und Schmerztherapie, Klinikum Ludwigsburg. NauhDi01@kliniken-lb.de
Geldner
Götz
G
D003472:Curare / Q000008:administration & dosage / Q000627:therapeutic use; D005703:Gallamine Triethiodide / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007440:Intubation / Q000379:methods; D008991:Monitoring, Physiologic / Q000295:instrumentation / Q000379:methods*; D009467:Neuromuscular Depolarizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D013569:Synapses / Q000187:drug effects / Q000502:physiology; D014110:Touch; D014403:Tubocurarine / Q000008:administration & dosage / Q000627:therapeutic use
D009467:Neuromuscular Depolarizing Agents; D003472:Curare; D005703:Gallamine Triethiodide; D014403:Tubocurarine